Purpose: To simulate the effect of supratuberosity tibial anterior closing-wedge osteotomy (ACWO) in knees with posterior tibial slope (PTS) ≥12° on patellar height when aiming for a target PTS of 5°.
Methods: The authors retrospectively reviewed true lateral radiographs of the knees of skeletally mature patients scheduled for primary anterior cruciate ligament reconstruction and included all knees with excessive PTS (≥12°). Coordinates of 11 landmarks were digitized to calculate patellar height (Caton-Deschamps index, CDI) and mid-shaft posterior tibial slope (mPTS). The change in patellar height following a simulated supratuberosity ACWO was calculated and compared for knees with patella norma versus alta. A linear univariable regression model predicted the effect of change in mPTS on CDI.
Results: In the final cohort of 83 patients, a simulated supratuberosity ACWO increased CDI from 1.13 (range, 0.73-1.74) to 1.29 (range, 0.84-1.91; P < .001). In 56 patients with patella norma, a simulated supratuberosity ACWO increased CDI from 1.02 (range, 0.73-1.19) to 1.18 (range, 0.84-1.41; P < .001), whereas in patients with patella alta, a simulated supratuberosity ACWO increased CDI from 1.33 (range, 1.20-1.74) to 1.52 (range, 1.36-1.91; P < .001). The linear regression model revealed that a 1° decrease in mPTS increased CDI by 0.02.
Conclusions: Simulation of a supratuberosity ACWO revealed that the procedure increases patellar height in all knees but did not induce significant differences in patellar height characteristics between knees with patella norma versus alta. A linear regression model revealed that a 1° decrease in mPTS could theoretically increase CDI by 0.02.
Clinical relevance: If preoperative planning indicates that supratuberosity ACWO would increase patellar height from norma (CDI <1.2) to alta (CDI ≥1.2), the surgeon could consider a trans- or infra-tuberosity ACWO, which is less likely to increase patellar height.
Copyright © 2023 Arthroscopy Association of North America. Published by Elsevier Inc. All rights reserved.